The Medicines Control
Authority of Zimbabwe (MCAZ) is looking to allow hemp-based CBD products to be
given as medicine to patients.
The MCAZ posted a letter to Twitter July 26 informing all licensed cannabis/hemp producers,
manufacturers, importers/exporters and retail pharmacists that the organization
is now accepting and reviewing applications for the approval of selling
hemp-based CBD products as complementary medicines to patients, under certain
conditions, Bloomberg reported.
Some conditions include
submitting product samples and a certificate of analysis, stating the
indications, warning and contraindications, and more.
The MCAZ stated at the end of
the letter, “Any hemp-based CBD product applications that do not meet the
criteria above may not be approved for distribution and will be confiscated.
Further, sellers may be prosecuted for selling unapproved complementary
medicines.”
